june 30, 2014 nih industry day matthew portnoy, ph.d. sbir/sttr program coordinator

51
National Institutes of Health Office of Extramural Research 1 Do Your Research – What you need to know about the business of Small Business Innovation Research (SBIR) June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator Office of Extramural Research, NIH

Upload: amie

Post on 23-Feb-2016

36 views

Category:

Documents


3 download

DESCRIPTION

Do Your Research – What you need to know about the business of Small Business Innovation Research (SBIR). June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator Office of Extramural Research, NIH. SBIR/STTR Programs Overview. SMALL BUSINESS INNOVATION - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

1

Do Your Research – What you need to know about the business of Small Business Innovation

Research (SBIR)

June 30, 2014NIH Industry Day

Matthew Portnoy, Ph.D.SBIR/STTR Program Coordinator

Office of Extramural Research, NIH

Page 2: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

2.8%

0.40%

SBIR/STTR Programs Overview

• SMALL BUSINESS INNOVATION • RESEARCH (SBIR) PROGRAM• Set-aside program for small business concerns to

engage in Federal R&D – with potential for commercialization

• SMALL BUSINESS TECHNOLOGY • TRANSFER (STTR) PROGRAM• Set-aside program to facilitate cooperative R&D between

small business concerns and U.S. research institutions – with potential for commercialization

Page 3: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

3

SBIR Purpose and Goals

• Stimulate technological innovation• Use small business to meet Federal R&D needs• Foster and encourage participation by minorities

and disadvantaged persons in technological innovation

• Increase private-sector commercialization innovations derived from Federal R&D

Small Business Innovation Development Act of 1982P.L. 112-81 Re-Authorizes program through FY2017

Page 4: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

4

STTR Purpose and Goals (cont.)

• Stimulate and foster scientific and technological innovation through cooperative research and development carried out between small business concerns and research institutions

• Foster technology transfer between small business concerns and research institutions

Small Business Research and Development Enhancement Act of 1992

P.L. 112-81 Re-Authorizes program through FY2017

Page 5: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

5

SBIR/STTR in Your Portfolio

• Capital is in the form of grants and contracts

• Strategic Investment in Innovation• Non-diluted funding:

– No repayment– No debt service– No equity forfeiture– No IP forfeiture

Page 6: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

6

SBIR/STTR Budgets by Agency FY2013

Agencies with SBIR & STTR Programs:• Department of Defense (DOD) = $1.0 B• Department of Health & Human Services:

National Institutes of Health (NIH) = $697.0 M• Department of Energy (DOE),including ARPA-E

= $183.9 M• National Science Foundation (NSF) = $153.0 M• National Aeronautics & Space Administration

(NASA) = $148.8 M

Page 7: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

7

SBIR/STTR Budgets by Agency FY2013 (continued)

Agencies with SBIR Programs:• U.S. Department of Agriculture (USDA) = $18.4 M• Department of Homeland Security (DHS): Science and Technology

Directorate (S&T) and Domestic Nuclear Detection Office (DNDO) = $15.7M

• Department of Education (ED) = $13.4 M• Department of Transportation (DOT) = $7.6 M• Department of Commerce: National Oceanic & Atmospheric

Administration (NOAA) and National Institute of Standards & Technology (NIST) = $7.4 M

• Environmental Protection Agency (EPA) = $3.8 M

~ $2.3B in FY13 across all agencies

Page 8: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

8

NIH Mission

To seek fundamental knowledge about the nature and behavior of living systems and

the application of that knowledge to enhance health, lengthen life, and reduce illness and

disability.

Page 9: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

National Institutes of Health

NIH Institutes, Centers and Offices

Page 10: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

10

NIH SBIR/STTR3-Phase Program

PHASE I Feasibility Study • Budget Guide: $150K (SBIR); $150K (STTR) Total Costs • Project Period: 6 months (SBIR); 1 year (STTR)

PHASE II Full Research/R&D• $1M (STTR), $1M (SBIR) over two years

PHASE IIB Competing Renewal/R&D• Clinical R&D; Complex Instrumentation/Tools to FDA• Many, but not all, ICs participate• Varies ~$1M/year; 3 years

PHASE III Commercialization Stage• NIH, generally, not the “customer”• Consider partnering and exit strategy early

Page 11: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

11

SBIR Eligibility Criteria

• Organized as for-profit U.S. business • Small: 500 or fewer employees, including affiliates• PD/PI’s primary employment must be with small business concern

at time of award and for duration of project period• Greater than 50% U.S.- owned by individuals and independently

operated or• Greater than 50% owned and controlled by other business

concern/s that is/are greater than 50% owned and controlled by one or more individuals or

• Be a concern which is more than 50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination of these

Page 12: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

12

STTR Eligibility Criteria

Applicant is Small Business Concern

Formal Cooperative R&D Effort • Minimum 40% by small business• Minimum 30% by U.S. research institution

U.S. Research Institution • College or university; other non-profit research organization;

Federal R&D center

Intellectual Property Agreement • Allocation of rights in IP and rights to carry out follow-on R&D and

commercialization

Page 13: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

13

PD/PI Eligibility on STTR

• PD/PI is not required to be employed by SBC

• PD/PI at RI must establish contract between RI and SBC describing PD/PI’s involvement

• PD/PI must commit a minimum of 10% effort

• PD/PI’s “signature” on application is agreement to conforming to Solicitation requirements

Page 14: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

14

SBIR and STTR Critical Differences

• Research Partner SBIR: Permits partnering

33% Phase I and 50% Phase II STTR: Requires partnering with research institution.

Small business (40%) and U.S. research institution (30%)

• Principal Investigator SBIR: Primary (>50%) employment must be with small business

concern STTR: PI may be employed by either research institution or small

business concernAward is always made

to Small Business Concern

Page 15: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

NIH SBIR/STTR Budget Allocations FY2014

• 2.8% SBIR $663M• 0.4% STTR $95M• Total FY2014 $758M

15

Page 16: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

HHS/NIH Program Funding

2014 BudgetNIH SBIR = $663M; STTR = $95MCDC SBIR = $8.97M; STTR = n/aFDA SBIR = $1.29M; STTR = n/aACF SBIR = $81K; STTR = n/aPhase I SBIR = $150K*, 6 months*; STTR = $150K*, 1 year*Phase II SBIR = $1M*, 2 years*; STTR = $1M*, 2 years*

Page 17: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Success Rate of SBIR/STTR 2012 and 2013 by Phase

SBIRFast Track: 2012 = 15.9%

2013 = 15.7%Phase 1:2012 = 15.6%

2013 = 13.2%Phase II: 2012 = 39.9%

2013 = 32.8%

STTRFast Track: 2012 = 34.4%

2013 = 28.6%Phase 1:2012 = 20.3%

2013 = 18.7%Phase II: 2012 = 39.4%

2013 = 26.4%

17

Page 18: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

NIH-wide SBIR/STTR Success Rates

Success Rates are Posted Online:

Fiscal Year SBIR/STTR PhaseNumber of

Applications Reviewed

Number of Applications

AwardedSuccess

Rate Total Funding

2012 SBIR Fast Track 358 57 15.9% $13,985,8022012 SBIR Phase 1 4,287 667 15.6% $154,237,8902012 SBIR Phase 2 557 222 39.9% $153,650,1622012 STTR Fast Track 32 11 34.4% $2,840,6322012 STTR Phase 1 542 110 20.3% $23,857,7002012 STTR Phase 2 71 28 39.4% $18,240,4182012 FY TOTAL 5,847 1,095 18.7% $366,812,6042013 SBIR Fast Track 313 49 15.7% $13,981,3862013 SBIR Phase I 3,738 495 13.2% $114,040,1572013 SBIR Phase II 542 178 32.8% $136,348,8462013 STTR Fast Track 42 12 28.6% $2,542,1282013 STTR Phase I 583 109 18.7% $24,138,6292013 STTR Phase II 72 19 26.4% $10,985,3732013 FY TOTAL 5,290 862 16.3% $302,036,519

Page 19: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

NIH SBIR/STTR Webpage

SBIR/STTR Webpage

Standard Due Dates:Apr. 5; Aug. 5; Dec. 5

Page 20: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

20

New sbir.nih.gov!

Page 21: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

21

Solicitations and Due Date

• NIH, CDC, FDA, & ACF SBIR/STTR Grant Solicitation “Parent” FOAs: SBIR: PA-14-071 STTR: PA-14-072 New SBIR Direct to Phase II FOA PAR-14-088 Release: January

Standard Due Dates: April 5, August 5, December 5(AIDS/AIDS-related: May 7, September 7, January 7)

• SBIR Contract Solicitation (NIH, CDC)Release: August November 2014 close date

• NIH Guide for Grants and ContractsRelease: Weekly Receipt dates specified in each FOA

Page 22: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Reauthorization Changes – Budget Hard Caps

• Reauthorization required that budgets over the hard cap ($225,000 for Phase I and $1,500,000 for Phase II) Agencies (not applicants) apply for waiver from SBA

• SBA has recently approved a topics list, which allows budgets to exceed the hard caps as long as the project topics are on the list

• Pre-approved topics list is Appendix A in regular topics document

• The approval is good for the 2014 SBIR/STTR Omnibus, and any FOA that falls on the topic list, including the Direct Phase II FOA

22

Page 23: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Other Reauthorization Changes

• Majority-owned venture capital provision

• Switching between SBIR and STTR

• SBIR Direct Phase II

Full list of changes located at the Grants & Funding website.

Questions? – Talk to your NIH IC Program Officer!

23

Page 24: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

24

Venture Capital Companies

• Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms ARE NOW ELIGIBLE to apply (NIH SBIR only).

• See NOT-OD-13-071

• SBIR and STTR VCOC forms are available

• *Note: SBIR VCOC form also used for SBIR contracts

Page 25: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Switching between SBIR and STTR

NIH SBIR/STTR applicants may now ‘switch’ programs at Phase II or Phase IIB to any active NIH SBIR or STTR solicitation.

Which means:• Phase I STTR Awardees may apply for NIH SBIR or STTR Phase II• Phase I SBIR Awardees may apply for NIH SBIR or STTR Phase II• Phase II STTR Awardees may apply for NIH SBIR or STTR Phase IIB• Phase II SBIR Awardees may apply for NIH SBIR or STTR Phase IIB

Note that not all NIH Institutes and Centers accept Phase IIB applications.  Check the Omnibus Topics document for listing.

25

Page 26: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

26

Helpful Tips:

• Must follow program rules (PI, % effort, sub-contracting, etc.)

• No special instructions or requirements from applicants

• NOT-OD-14-048

• Applicants are strongly advised to discuss this option with their program officer well in advance of any due date.

Switching between SBIR and STTR (cont.)

Page 27: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Direct to Phase II SBIR FOA

• Allows small businesses that are ready for the Phase II stage of development to bypass applying for a Phase I grant.

• The SBC must already have a technology prototype, and must have tested its feasibility (i.e. completed Phase-I-type R&D) to move directly into a Phase-II-type R&D.

• Pilot SBIR Direct to Phase II Solicitation – it’s own SEPARATE FOA: PAR-14-088.

• Note: Not all ICs will accept Direct Phase IIs – only the ones listed on the solicitation. SBCs cannot apply for a Phase II and Direct Phase II for the same research project.

27

Page 28: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

28

• All ICs on the Direct Phase II FOA will accept technology on anything within their mission. Note: NINDS has a few exceptions listed within the FOA.

• Applicants are strongly advised to talk to their SBIR Program Officer before applying.

• Some ICs may issue their own separate Direct Phase II FOA/s in the future.

Direct to Phase II SBIR FOA (2)

Page 29: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

29

• A Direct Phase II is not a Phase IIB!

• No due dates past 12/5/2016 standard date.

• The Direct-to-Phase II authority is not available to the STTR program and not available for the CDC, FDA, and ACF SBIR programs.

Direct to Phase II SBIR FOA (3)

Page 30: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Direct to Phase II SBIR FOA (4)

How is a Direct Phase II different than a fast-track?

• A FT incorporates a submission and review process in which both Phase I and Phase II grant applications are submitted and reviewed together as one application

• Intended to reduce or eliminate the funding gap between phases

Which one is right for you? • Talk to your SBIR Program Officer!

30

Page 31: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Direct to Phase II SBIR FOA (5)

What is the review process?

• Application goes to NIH Center for Scientific Review.

• Application is assigned a small business study section.

• Review staff have guidance on the new FOA,

• It’s too early to know the volume or the success rate!

31

Page 32: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

32

SBIR/STTR Program Descriptions & Research Topics

Our Ideas: Suggested topic areas*BiodefenseBiosensorsNanotechnologiesBioinformaticsDiagnostic and Therapeutic DevicesTelehealthProteomics / GenomicsBiosilicon devicesBiocompatible materialsAcousto-optics / opto-electronicsHealth ITImaging devicesGenetically engineered proteins

Page 33: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

33

SBIR/STTR Program Descriptions & Research Topics (cont.)

Your Ideas: Investigator-initiated R&D • Research projects related to the NIH

mission• “Other” areas of research within the

mission of an awarding component Keyword search the Solicitation Ctrl - F

Page 34: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Electronic Submission

SBIR/STTR grant applications must be submitted electronically. SBIR contract proposals still in paper form.

Registrations are required!!!System for Award Management (SAM)Grants.gov (company) eRA Commons (company and all PD/PIs)SBA company registry at SBIR.gov

Page 35: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Most Important Piece of Advice

• Talk to an NIH Program Officer about your application and SUBMIT EARLY (days not hours and minutes)! – Program Officer contact information found in the NIH

SBIR/STTR Solicitation

– Questions about who to contact? Email [email protected]

Page 36: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

36

Application & Review Process

1. Small Business Concern (Applicant Initiates Research Idea)

2. Submits SBIR/STTR Grant Application to NIH Electronically

3. NIH Center for Scientific Review Assign to IC and IRG4. Scientific Review Groups Evaluate Scientific Merit – (~2-

3 months after submission)5. Advisory Council or Board Recommend approval – (~2-3

months after review)6. IC Staff Prepare funding Plan for IC Director7. IC Allocates Funds8. Grantee Conducts Research

Page 37: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

37

Review Criteria

Overall Impact Score

Scored Review Criteria (score 1-9) Significance (Real Problem/Commercial Potential) Investigators (PI and team) Innovation (New or Improved?) Approach (Research Design, Feasible) Environment (Facilities/Resources)

Additional Review Criteria (not scored individually) Protection of Human Subjects Inclusion of Women, Minorities & Children Vertebrate Animals Biohazards

Page 38: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

38

Timeline: New Applications

Entire Process = 6-9 months Due Date - April 5

Scientific Review – JulyCouncil Review – OctoberAward Date (earliest) – December

Due Date - August 5Scientific Review – NovemberCouncil Review – JanuaryAward Date (earliest) – April

Due Date - December 5Scientific Review – MarchCouncil Review – MayAward Date (earliest) – July

Page 39: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

39

Common Application Problems

• No Significance Unimportant problem, unconvincing case for commercial

potential or societal impact• Inadequately defined test of feasibility• Lack of innovation • Diffuse, superficial, or unfocused research plan• Questionable reasoning in experimental approach

Failure to consider potential pitfalls and alternatives• Lack of experience with essential methodologies• Unfamiliar with relevant published work• Unrealistically large amount of work proposed

Page 40: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

40

Competing Successfully for SBIR/STTR Funding

• Understand our mission• Review Funding Opportunity Announcements (FOAs)• Propose innovative ideas with significance as well as

scientific and technical merit• Give yourself ample time to prepare application• Communication, Communication, Communication• Contact NIH Staff to discuss

– your research idea– outcome of your review– challenges and opportunities

Page 41: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

41

NIH SBIR/STTR: 3-Phase Program Plus Gap Funding

• Phase I – Feasibility• Phase II – Full R&D

(Phase I Phase II Fast Track)Phase II Competing Renewal Award

($3M/3 years)• Phase III

Page 42: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

42

NIH Phase I/Phase II Fast-Track

SBIR/STTR Phase I + Phase II(Simultaneous Submission and Concurrent Review)

7-9 months to Phase I Award

Completion of Phase IPhase I Final ReportProgram Staff assess completion of specific aims and milestones

Go? Aims/Milestones Met = Phase II award

No Go? Aims/Milestones NOT Met = Phase II no award

Page 43: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

43

Phase IIB Competing Renewal Award

Parameters• SBIR/STTR Phase II awardee• Promising pharmacologic compound identified in original Phase II• Device prototype developed in original Phase II• Instrumentation/Interventional technologies not subject to FDA regulatory

approval but require extraordinary time/effort to develop

• Awards up to $1M/year for up to 3 years • IC must accept Competing Renewal applications

(NIA, NIAAA, NIAID, NICHD, NIDA, NIDCD, NIDDK, NEI, NIGMS, NHLBI, NIMH, NINDS, NCATS, ORIP, NCI, NHLBI, NINDS)

Contact NIH Program Staff to discuss!

Page 44: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Niche Assessment Program

• Provides active Phase I awardees with market research, and consumer and competition analysis

• Helps small businesses complete their commercialization plans as part of their Phase II applications

• Learn more at the Niche Assessment Program website

Page 45: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

Commercialization Assessment

• Trains Phase II awardees to:– Develop tailored market entry strategies; – Build strategic partnerships;– Develop FDA regulatory and reimbursement

paths; and– Identify financing strategies and expertise on

intellectual property matters

– Learn more at the Commercialization Assistance Program (CAP) website

Page 46: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

NIH SBIR/STTR Program Summary of Key Features

SBIR and STTR Program• Single SBIR/STTR grant solicitation• Investigator-initiated research ideas• Special Funding Opportunities (NIH Guide for Grants & Contracts)• Electronic Submission (grants only)• Awards: Grants, Contracts, Cooperative Agreements

External Peer Review• Option to request review group• Experts from academia/industry• Five Criteria: Significance, Approach, PI(s), Innovation, Environment• Summary statement for all applicants• Revise & resubmit

Multiple Receipt Dates (Grants)• April 5, August 5, December 5• May 7, Sept. 7, Jan. 7 (AIDS)• Contracts: November

Page 47: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

NIH SBIR/STTR Program Summary of Key Features (cont.)

Gap Funding Programs • Phase IIB Competing Renewals• Phase I/Phase II Fast Track • Administrative Supplements

Budget and Project Period• $150K/6 - 12 months (Phase I)• $1M/2 years (Phase II)

Technical Assistance Programs • Technology Niche Assessment• Commercialization Assistance

47

Page 48: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

48

For More Information

Matthew Portnoy, PhDNIH SBIR/STTR Program CoordinatorPhone: 301- 435-2688Email: [email protected] Fedorkova, PhDSBIR/STTR Asst. Program ManagerPhone: 301-435-0921Email: [email protected] VinsonSBIR/STTR Asst. Program ManagerPhone: 301-435-2713Email: [email protected] RoysterSBIR/STTR Communications SpecialistPhone: 301-402-1632Email: [email protected] BeaverSBIR/STTR StatisticianPhone: 301-496-8807Email: julie.beaver@nih.

Page 49: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

49

More Information

Get Connected!

• Subscribe to the SBIR/STTR Listserv: Email [email protected] with the following text in the message body: subscribe SBIR-STTR your name

• NIH Guide for Grants and Contracts (weekly notification)

• Follow us on Twitter: @NIHsbir

• Submit your SBIR/STTR Success Story

• Email: [email protected]

Page 50: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

50

Save the Date

16th Annual NIH SBIR/STTR Conference

• October 21 – 23, 2014

• Albuquerque, New Mexico

• Host: University of New Mexico Health Sciences Center

• Early Bird Registration $350 through 8/22/14

Page 51: June 30, 2014 NIH Industry Day Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator

National Institutes of HealthOffice of Extramural Research

51

Questions

Questions and Answers!